Efficacy and safety of long-term macrolide therapy for non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis (vol 62, pg 1079, 2024)

被引:0
作者
Nakagawa, Natsuki [1 ]
Ito, Masashi [2 ,3 ]
Asakura, Takanori [4 ,5 ]
Horita, Nobuyuki [6 ]
Obase, Yasushi [7 ]
Mukae, Hiroshi [7 ]
机构
[1] Univ Tokyo Hosp, Dept Resp Med, Bunkyo Ku, Tokyo, Japan
[2] Fukujuji Hosp, Resp Dis Ctr, Japan AntiTB Assoc, Tokyo, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Mycobacteriosis, Nagasaki, Japan
[4] Kitasato Univ, Sch Pharm, Dept Clin Med, Lab Bioregulatory Med, Tokyo, Japan
[5] Kitasato Univ, Kitasato Inst Hosp, Dept Resp Med, Tokyo, Japan
[6] Yokohama City Univ Med, Chemotherapy Ctr, Yokohama, Japan
[7] Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Med, Nagasaki, Japan
关键词
D O I
10.1016/j.resinv.2025.01.002
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:224 / 225
页数:2
相关论文
共 1 条
[1]   Efficacy and safety of long-term macrolide therapy for non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis [J].
Nakagawa, Natsuki ;
Ito, Masashi ;
Asakura, Takanori ;
Horita, Nobuyuki ;
Obase, Yasushi ;
Mukae, Hiroshi .
RESPIRATORY INVESTIGATION, 2024, 62 (06) :1079-1087